Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable

被引：0
作者：
Picado, Albert [1 ]
Rijal, Suman [2 ]
Sundar, Shyam [3 ]
Boelaert, Marleen [4 ]
机构：
[1] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, E-08036 Barcelona, Spain
[2] BP Koirala Inst Hlth Sci, Dharan, Nepal
[3] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India
[4] Inst Trop Med, B-2000 Antwerp, Belgium
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2012年 / 10卷 / 08期
关键词：
access to treatment; India; kala-azar; liposomal amphotericin B; miltefosine; Nepal; poverty; socioeconomic; visceral leishmaniasis; LIPOSOMAL AMPHOTERICIN-B; PERFORMANCE; ELIMINATION; BIHAR;
D O I：
10.1586/ERI.12.71
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：839 / 841
页数：3
相关论文
共 26 条
[1]   Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences [J].
Adhikari, Shiva R. ;
Maskay, Nephil M. ;
Sharma, Bishnu P. .
HEALTH POLICY AND PLANNING, 2009, 24 (02) :129-139
[2]   Leishmaniasis and poverty [J].
Alvar, Jorge ;
Yactayo, Sergio ;
Bern, Caryn .
TRENDS IN PARASITOLOGY, 2006, 22 (12) :552-557
[3]   Leishmaniasis Worldwide and Global Estimates of Its Incidence [J].
Alvar, Jorge ;
Velez, Ivan D. ;
Bern, Caryn ;
Herrero, Merce ;
Desjeux, Philippe ;
Cano, Jorge ;
Jannin, Jean ;
den Boer, Margriet .
PLOS ONE, 2012, 7 (05)
[4]   The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India [J].
Boelaert, M. ;
Meheus, F. ;
Sanchez, A. ;
Singh, S. P. ;
Vanlerberghe, V. ;
Picado, A. ;
Meessen, B. ;
Sundar, S. .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (06) :639-644
[5]   A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis [J].
Chappuis, Francois ;
Rijal, Suman ;
Soto, Alonso ;
Menten, Joris ;
Boelaert, Marleen .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7571) :723-726
[6]   The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness [J].
Chowdhury, R. ;
Huda, M. M. ;
Kumar, V. ;
Das, P. ;
Joshi, A. B. ;
Banjara, M. R. ;
Akhter, S. ;
Kroeger, A. ;
Krishnakumari, B. ;
Petzold, M. ;
Mondal, D. ;
Das, M. L. .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2011, 105 (01) :31-45
[7]   Leishmaniasis impact and treatment access [J].
den Boer, M. ;
Argaw, D. ;
Jannin, J. ;
Alvar, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (10) :1471-1477
[8]  
Hasker E, 2012, EMERG INFECT DIS IN
[9]  
Hasker E., 2010, TROP MED INT HEALTH, P55
[10]   India: Towards Universal Health Coverage 1 Continuing challenge of infectious diseases in India [J].
John, T. Jacob ;
Dandona, Lalit ;
Sharma, Vinod P. ;
Kakkar, Manish .
LANCET, 2011, 377 (9761) :252-269
123